AsthmaMap: An interactive knowledge repository for mechanisms of asthma

TY - JOUR

T1 - AsthmaMap: An interactive knowledge repository for mechanisms of asthma

AU - Mazein, Alexander

AU - Ivanova, Olga

AU - Balaur, Irina

AU - Ostaszewski, Marek

AU - Berzhitskaya, Valeriya

AU - Serebriyskaya, Tatiana

AU - Ligon, Thomas

AU - Hasenauer, Jan

AU - de Meulder, Bertrand

AU - Overall, Rupert W.

AU - Roy, Ludovic

AU - Knowles, Richard G.

AU - Wheelock, Craig E.

AU - Dahlen, Sven-Erik

AU - Chung, Kian Fan

AU - Adcock, Ian M.

AU - Roberts, Graham

AU - U-BIOPRED study group

AU - eTRIKS Consortium

AU - Djukanovic, Ratko

AU - Pellet, Johann

AU - Gawron, Piotr

AU - Balling, Rudi

AU - Maitland-van der Zee, Anke H.

AU - Schneider, Reinhard

AU - Sterk, Peter J.

AU - Auffray, Charles

N1 - Funding Information: The AsthmaMap project progresses in alliance with the efforts of the Disease Maps Community (https://disease-maps.org). Disclosure of potential conflict of interest: S.-E. Dahlen reports personal fees from AstraZeneca, Boehringer-Ingelheim, Cayman Chemicals, GlaxoSmithKline (GSK), Novartis, Regeneron, Roche, Sanofi, and Teva outside the submitted work. K. F. Chung has received honoraria for participating in advisory board meetings of GSK, AstraZeneca, Roche, Novartis, Merck, BI, TEVA, and Shionogi regarding treatments for asthma, chronic obstructive pulmonary disease, and chronic cough and has also been remunerated for speaking engagements. R. Balling is a founder and a shareholder of MEGENO S.A. and a shareholder of ITTM S.A. R. Djukanovic reports receiving fees for lectures at symposia organized by Novartis, AstraZeneca, and TEVA; consultation for TEVA and Novartis as member of advisory boards; participation in a scientific discussion about asthma organized by GSK; and is a cofounder and current consultant and has shares in Synairgen, a University of Southampton spin-out company. A. H. Maitland-van der Zee reports grants and personal fees from Boehringer Ingelheim and GSK, grants from Vertex, and personal fees from AstraZeneca, all paid to her institution, and, in a public-private partnership, sponsored by Health Holland matching grants from Boehringer Ingelheim, Breathomix, Fluidda, Ortec Logiqcare, Philips, Quantib-U, Smartfish, SODAQ, Thirona, TopMD, and Novartis outside the submitted work. R. Schneider is a founder and a shareholder of MEGENO S.A. and ITTM S.A. P. J. Sterk is a scientific adviser and officially has a nonsubstantial interest in the start-up company Breathomix BV, which produces eNoses and accompanying cloud algorithms. The rest of the authors declare that they have no relevant conflicts of interest.

PY - 2021/3

Y1 - 2021/3

KW - Asthma

KW - data interpretation

KW - disease map

KW - disease mechanisms

KW - knowledge representation

UR - http://www.scopus.com/inward/record.url?scp=85099532947&partnerID=8YFLogxK

U2 - https://doi.org/10.1016/j.jaci.2020.11.032

DO - https://doi.org/10.1016/j.jaci.2020.11.032

M3 - Editorial

C2 - 33309742

SN - 0091-6749

VL - 147

SP - 853

EP - 856

JO - Journal of allergy and clinical immunology

JF - Journal of allergy and clinical immunology

IS - 3

ER -